| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.25 (Beat by $0.02) |
| EPS GAAP Actual | $0.25 (Beat by $0.02) |
| Revenue Actual | $0.697264B |
| Revenue Surprise | Beat by $697.264M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.41822 |
| EPS GAAP Estimate | $0.41822 |
| Revenue Estimate | $2.74091529B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 3.11 | 0.86 | 3.05076 | 3.17366 | 1 |
| Dec 2029 | 1.42 | 1.89 | 1.32719 | 1.80632 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.94 | -2.3733 | 0.697264B | -290.26% | -1989.98M |
| FQ2 2025 (Jun 2025) | -11.3 | -11.72664 | 0.681917B | -291.69% | -2005.33M |
| FQ1 2025 (Mar 2025) | -0.32 | -0.32 | 2.63205B | 0.74% | 2632.05M |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 2.69607B | 1.48% | 2696.07M |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 2.72113B | 4.76% | 2721.13M |
| FQ2 2024 (Jun 2024) | -0.42 | -0.42 | 2.67101B | 4.04% | 2671.01M |
| FQ1 2024 (Mar 2024) | -0.29 | -0.29 | 2.61268B | 3.44% | 2612.68M |
| FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 2.65615B | 12.2% | 2656.15M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.41822
Consensus Revenue Estimates
2.74091529B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.92253 | -- | 0.91331 | 0.93047 | 1 |
| FQ3 2027 (Sep 2027) | 0.77256 | -- | 0.75642 | 0.78336 | 1 |
| FQ2 2027 (Jun 2027) | 0.55884 | -- | 0.54716 | 0.56665 | 1 |
| FQ1 2027 (Mar 2027) | 0.37013 | -- | 0.3624 | 0.37531 | 1 |
| FQ4 2026 (Oct 2026) | 0.65006 | -- | 0.64847 | 0.65165 | 0 |
| FQ3 2026 (Jul 2026) | 0.54469 | 456.17 | 0.54336 | 0.54602 | 0 |
| FQ2 2026 (Jun 2026) | 0.54469 | 2174.57 | 0.54469 | 0.54469 | 0 |
| FQ1 2026 (Mar 2026) | 0.41822 | 176.51 | 0.41822 | 0.41822 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.01B | -- | 2.99B | 3.03B | 2 |
| FQ3 2027 (Sep 2027) | 2.97B | -- | 2.92B | 3B | 2 |
| FQ2 2027 (Jun 2027) | 2.95B | -- | 2.9B | 2.98B | 2 |
| FQ1 2027 (Mar 2027) | 2.89B | -- | 2.84B | 2.92B | 2 |
| FQ4 2026 (Oct 2026) | 2.8B | -- | 2.79B | 2.8B | 1 |
| FQ3 2026 (Jul 2026) | 2.77B | 74.79 | 2.76B | 2.77B | 1 |
| FQ2 2026 (Jun 2026) | 2.77B | 75.34 | 2.77B | 2.77B | 1 |
| FQ1 2026 (Mar 2026) | 2.74B | 3.97 | 2.74B | 2.74B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.4333 | -1.94 | -2.3733 | 122.34% |
| FQ2 2025 (Jun 2025) | 0.42664 | -11.3 | -11.72664 | 103.78% |
| FQ1 2025 (Mar 2025) | -0.32 | -0.32 | 100% | |
| FQ4 2024 (Dec 2024) | -3.84 | -3.84 | 100% | |
| FQ3 2024 (Sep 2024) | -0.17 | -0.17 | 100% | |
| FQ2 2024 (Jun 2024) | -0.42 | -0.42 | 100% | |
| FQ1 2024 (Mar 2024) | -0.29 | -0.29 | 100% | |
| FQ4 2023 (Dec 2023) | 0.23 | 0.23 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.69B | $0.7B | $-1989.98M | -285.4% |
| FQ2 2025 (Jun 2025) | $2.69B | $0.68B | $-2005.33M | -294.07% |
| FQ1 2025 (Mar 2025) | $0B | $2.63B | $2632.05M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.7B | $2696.07M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.72B | $2721.13M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.67B | $2671.01M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.61B | $2612.68M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.66B | $2656.15M | 100% |